As described, a set of five different shRNAs, targeting non-overlapping sequences of NSD3 (“shNSD3-S1/2/3/4/5”), were individually transduced to primary human pancreatic cancer cells (“PanCa-1”). Here, NSD3 is linked to pancreatic neoplasm.